Measuring normal and pathological anxiety-like behaviour in mice: A review

Behavioural Brain Research

Volumn 125, Issue 1-2, 2001, Pages 141-149

  Belzung, Catherine ^a   Griebel, Guy ^b  

^a EA 3248 Psychobiologie des Emotions   (France)

^b SANOFI   (France)

Author keywords

Anxiety; BALB c mice; Elevated plus maze; Free exploration test; Mouse; Openfield; Predator elicited defensive responses

Indexed keywords

ANIMAL BEHAVIOR; ANIMAL MODEL; ANXIETY; ANXIETY NEUROSIS; CONFERENCE PAPER; DISEASE MODEL; GENE TARGETING; INBRED STRAIN; LIGHT DARK CYCLE; MAZE TEST; MOUSE STRAIN; NONHUMAN; OPEN FIELD TEST; PRIORITY JOURNAL;

ANIMALS; ANXIETY; AROUSAL; BEHAVIOR, ANIMAL; HUMANS; MICE; MICE, INBRED BALB C; MICE, INBRED STRAINS; MICE, KNOCKOUT; MICE, MUTANT STRAINS; MICE, TRANSGENIC; MODELS, GENETIC; PHENOTYPE;

EID: 0035829390     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-4328(01)00291-1     Document Type: Conference Paper

References (90)

1. Blockade of anxiolytic-like actions of chlordiazepoxide by naloxone in the elevated plus-maze: Comparisons between Swiss, C57BL/6 and BALB/c mice
2. IL-6 deficiency leads to increased emotionality in mice: Evidence in transgenic mice carrying a null mutation for IL-6
3. Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behaviour and are hypersensitive to stress
4. Behavioral characterization of neuropeptide Y knockout mice
5. Naloxone blocks anxiolytic-like effects of benzodiazepines in Swiss but not in BALB/c mice
6. Naloxone potentiates the effects of subeffective doses of anxiolytic agents in mice
7. Differences in drug-induced place conditioning between BALB/c and C57Bl/6 mice
8. Naloxone potentiates the anxiolytic but not the amnestic action of chlordiazepoxide in C57BL/6 mice
9. Flumazenil induces benzodiazepine partial agonist-like effects in BALB/c but not C57BL/6 mice
10. Link between emotional memory and anxiety states: A study by principal component analysis
11. Further investigations on the anxiogenic action of isatin
12. Affect and aggression: An animal model applied to human behavior
13. The characterization and modelling of antipredator defensive behavior
14. Differentiation of anxiolytic and panicolytic drugs by effects on rat and mouse defense test batteries
15. Maternal care during infancy regulates the development of neural systems mediating the expression of fearfulness in the rat
16. Emotional reactivity in mice: A case of non-genetic heredity?
17. Paradoxical differences in animal models of anxiety among the Roman rat lines
18. Genetic difference in sensitivity to beta-carboline: Evidence for the involvement of brain benzodiazepine receptors
19. Mice trisomic for a bacterial artificial chromosome with the single-minded 2 gene (SIM2) show phenotypes similar to some of those present in the partial trisomy 16 mouse models of down syndrome
20. Sardinian alcohol-preferring rats: A genetic animal model of anxiety
21. Abnormal adaptations to stress and impaired cardiovascular function in mice lacking corticotropin-releasing hormone receptor-2
22. A-receptor clustering results in enhanced anxiety and a bias for threat cues
23. Carboline-induced seizures in mice: Genetic analysis
24. Dopamine D4 receptor-knock-out mice exhibit reduced exploration of novel stimuli
25. Exploratory and displacement behavior in transgenic mice expressing high levels of brain TNF-alpha
26. Superior water maze performance and increase in fear-related behavior in the endothelial nitric oxide synthase-deficient mouse together with monoamine changes in cerebellum and ventral striatum
27. Gene-targeting studies of mammalian behavior: Is it the mutation or the background genotype?
28. Catechol-O-methyltransferase-deficient mice exhibit sexually dimorphic changes in catecholamine levels and behavior
29. Comparison of anxiety measured in the elevated plus-maze, open-field and social interaction tests between spontaneously hypertensive rats and Wistar EPM-1 rats
30. Is there a future for neuropeptide receptor ligands in the treatment of anxiety disorders?
31. The free-exploratory paradigm: An effective method for measuring neophobic behaviour in mice and testing potential neophobia-reducing drugs
32. Differences in anxiety-related behaviours and in sensitivity to diazepam in inbred and outbred strains of mice
33. A model of 'antipredator' defense in Swiss-Webster mice: Effects of benzodiazepine receptor ligands with different intrinsic activities
34. 5-Hydroxytryptamine-interacting drugs in animal models of anxiety disorders: More than 30 years of research
35. The mouse defense test battery: An experimental model of different emotional states
36. Anti-sexual and anxiogenic behavioral consequences of corticotropin-releasing factor overexpression are centrally mediated
37. Elevated anxiety and antidepressant-like responses in serotonin 5-HT1A receptor mutant mice
38. Difference in the reactivity of the mesocortical dopaminergic neurons to stress in the BALB/c and C57 BL/6 mice
39. A review of the validity and variability of the elevated plus-maze as an animal model of anxiety
40. Normal electrophysiological and behavioral responses to ethanol in mice lacking the long splice variant of the γ2 subunit of the γ-aminobutyrate type A receptor
41. Effects on blood pressure and exploratory behaviour of mice lacking angiotensin II type-2 receptor
42. Anxiety-like behavior in transgenic mice with brain expression of neuropeptide Y
43. Altered anxiety and weight gain in corticotropin-releasing hormone-binding protein-deficient mice
44. Increased anxiety and altered responses to anxiolytics in mice deficient in the 65-kDa isoform of glutamic acid decarboxylase
45. Deletion of Crhr2 reveals an anxiolytic role for corticotropin-releasing hormone receptor-2
46. Pain responses, anxiety and aggression in mice deficient in pre-proenkephalin
47. Targeted disruption of the orphanin FQ/nociceptin gene increases stress susceptibility and impairs stress adaptation in mice
48. The influence of a targeted deletion of the IFNgamma gene on emotional behaviors
49. Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A2a receptor
50. Effects of buspirone on antinociceptive and behavioural responses to the elevated plus-maze in mice
51. Ethologically-based animal models of anxiety disorders
52. The use of a plus-maze to measure anxiety in the mouse
53. Temporal structure of open-field behavior in inbred strains of mice
54. Animal models of depression: An overview
55. Animal model of depression. I. Review of evidence: Implications for research
56. Stimulation of 5-HT1A receptors by systemic or medial septum injection induces anxiogenic-like effects and facilitates acquisition of a spatial discrimination task in mice
57. Does neophobia necessarily imply fear or anxiety?
58. Increased fearfulness of Fyn tyrosine kinase deficient mice
59. Disruption of the midkine gene (MDK) resulted in altered expression of a calcium binding protein in the hippocampus of infant mice and their abnormal behaviour
60. Anxiety-induced antinociception in mice: Effects of systemic and intra-amygdala administration of 8-OH-DPAT and midazolam
61. Behavioral effects of estrogen receptor gene disruption in male mice
62. Anxiety-like behavior in mice lacking the angiotensin II type-2 receptor
63. Increased anxiety and impaired pain response in puromycin-sensitive aminopeptidase gene-deficient mice obtained by a mouse gene-trap method
64. Life without neuropeptide Y
65. Increased anxiety of mice lacking the serotonin1A receptor
66. Does the 5-HT1A receptor knockout mouse have an anxious phenotype?
67. Serotonin receptor 1A knockout: An animal model of anxiety-related disorder
68. Altered physiological and behavioral responses in CRH-binding protein deficient mice
69. Benzodiazepine receptors in 'emotional' and 'non emotional' mice: Comparison of four strains
70. Animal models of anxiety: An ethological perspective
71. The elevated plus-maze: Pharmacology, methodology and ethology
72. Anxiogenic-like effects of fluprazine and eltoprazine in the mouse elevated plus-maze: Profile comparisons with 8-OH-DPAT, CGS 12066B, TFMPP and mCPP
73. Factor analysis of spatiotemporal and ethological measures in the murine elevated plus-maze test of anxiety
74. Phenotypic characterization of an alpha(4) neuronal nicotinic acetylcholine receptor subunit knock-out mouse
75. Discovery of the antidepressant and anti-emetic efficacy of substance P receptor (NK1) antagonists
76. Animal models of anxiety and the development of novel anxiolytic drugs
77. Anxiolysis by ethanol, diazepam and buspirone in a novel murine behavioral assay
78. CRH overproduction in transgenic mice: Behavioral and immune system modulation
79. Anxiety and increased 5-HT1A receptor response in NCAM null mutant mice
80. Animal models for the study of anti-anxiety agents: A review
81. Diazepam disposition in mature and aged rabbits and rats
82. The effects of childhood parental death and divorce on six-month history of anxiety disorders
83. CCKB receptor knockout mice: Gender related behavioural differences
84. Sustained long term potentiation and anxiety in mice lacking the Mas protooncogene
85. Measurement of anxiety in transgenic mice
86. Chronic mild stress-induced anhedonia: A realistic animal model of depression